SeQuent Scientific Ltd
NSE:SEQUENT

Watchlist Manager
SeQuent Scientific Ltd Logo
SeQuent Scientific Ltd
NSE:SEQUENT
Watchlist
Price: 201.17 INR 3.71% Market Closed
Market Cap: 50.8B INR

Operating Margin

6.2%
Current
Improving
by 4.3%
vs 3-y average of 1.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
6.2%
=
Operating Income
₹992.9m
/
Revenue
₹16B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
6.2%
=
Operating Income
₹992.9m
/
Revenue
₹16B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
SeQuent Scientific Ltd
NSE:SEQUENT
50.4B INR
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.3B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.5B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
CH
Novartis AG
SIX:NOVN
220.8B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
271.4B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
148.1B USD
Loading...

Market Distribution

In line with most companies in India
Percentile
45th
Based on 5 437 companies
45th percentile
6.2%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

SeQuent Scientific Ltd
Glance View

Market Cap
50.8B INR
Industry
Pharmaceuticals

SeQuent Scientific Ltd. manufactures and produces veterinary pharmaceuticals and specialty chemicals. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2016-03-10. The firm operates in the domains of animal health, in which it provides active pharmaceutical ingredient (APIs) and finished dosage formulations, and analytical services. The firm through its subsidiary, Alivira Animal Health Limited, offers APIs and formulations. Alivira Animal Health Limited has manufacturing facilities in five countries, including India. The Company’s subsidiary, Sequent Research Limited, is a contract research organization, which is engaged in analytical and biological analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. Sequent Research Limited provides complete analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopeial monographs, customer-developed methods or in-house method development.

SEQUENT Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
6.2%
=
Operating Income
₹992.9m
/
Revenue
₹16B
What is SeQuent Scientific Ltd's current Operating Margin?

The current Operating Margin for SeQuent Scientific Ltd is 6.2%, which is above its 3-year median of 1.9%.

How has Operating Margin changed over time?

Over the last 3 years, SeQuent Scientific Ltd’s Operating Margin has increased from 3% to 6.2%. During this period, it reached a low of -2.8% on Jun 30, 2023 and a high of 6.5% on Mar 31, 2025.

Back to Top